Treatment of acute myeloid leukemia
- 1 January 2009
- journal article
- editorial
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 94 (1), 10-16
- https://doi.org/10.3324/haematol.2008.001263
Abstract
The treatment of acute myeloid leukemia has improved in the last ten years, and in this perspective article Dr. Estey examines the recent progress in this field. See related articles on pages 54 and 102.Keywords
This publication has 28 references indexed in Scilit:
- Acute myeloid leukaemiaThe Lancet, 2006
- Further Analysis of Trials With Azacitidine in Patients With Myelodysplastic Syndrome: Studies 8421, 8921, and 9221 by the Cancer and Leukemia Group BJournal of Clinical Oncology, 2006
- Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemiaBlood, 2006
- New designs for phase 2 clinical trialsBlood, 2003
- The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trialBlood, 2001
- The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.1998
- Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.1998
- Implications of potential cure in acute myelogenous leukemia: development of subsequent cancer and return to work.1997
- Prediction of survival during induction therapy in patients with newly diagnosed acute myeloblastic leukemia.1989
- The effect of chemotherapy on acute leukemia in the humanJournal of Chronic Diseases, 1961